Alan G. Harris

Alan G. Harris

Geen lopende functies
74 jaar
Health Technology
Consumer Services
Commercial Services

Profiel

Alan G.
Harris
is the founder of SomPharmaceuticals GmbH, which was founded in 2012.
He held the title of Chairman at the time of founding.
Dr. Harris's former jobs include Chairman-Research Development Sub Committee at Biotechnology Innovation Organization, Medical Director-Technology Department at Cedars-Sinai Medical Center, Senior Research & Development Executive at Schering-Plough Corp., Chief Medical Officer & Senior Vice President at NPS Pharmaceuticals, Inc., Chief Medical Officer at TG Therapeutics, Inc., Chief Medical Officer at Radius Health, Inc., Senior Research & Development Executive at Novartis Corp., Chief Medical Consultant at Celsus Therapeutics Plc, Associate Professor at the University of California, Los Angeles, Senior Research & Development Executive at Pfizer Ltd., and VP-Drug Development & Regulatory Affairs at Caladrius Biosciences, Inc. Dr. Harris's education includes a doctorate from Erasmus University Rotterdam and a doctorate from the University of Strasbourg.

Eerdere bekende functies van Alan G. Harris

BedrijvenFunctieEinde
TG THERAPEUTICS, INC. Hoofd Techniek/Wetenschap/O&O 27-12-2007
Corporate Officer/Principal -
Directeur/Bestuurslid 01-01-1998
Hoofd Techniek/Wetenschap/O&O 01-01-1994
Oprichter -
Ervaring van Alan G. Harris in detail bekijken

Opleiding van Alan G. Harris

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

62

Eerstegraads connecties

14

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit14

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Consumer Services

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Alan G. Harris
40 % korting: de beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU